TURK ILAC VE SERUM SANAYI ANONIM SIRKETI

Turk Ilac Ve Serum Sanayi Anonim Sirketi

TRILC

TRETRLC00022

Pharmaceuticals

Delayed Borsa Istanbul Other stock markets 04:30:59 2024-04-29 am EDT			5-day change	1st Jan Change
23.88 ^TRY	+2.23%		+6.53%	+108.40%

Apr. 04	Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.

February 14, 2023

The Board of Directors of Turk Ilac Ve Serum Sanayi Anonim Sirketi has authorized a buyback plan on February 15, 2023.

Latest news about Turk Ilac Ve Serum Sanayi Anonim Sirketi

Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 04	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-27	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-02	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi announces an Equity Buyback for 1,000,000 shares, for TRY 12 million.	23-02-15	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.	23-02-14	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-10	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi(IBSE:TRILC) dropped from S&P Global BMI Index	22-09-19	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-01	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi announces an Equity Buyback for 1,000,000 shares, for TRY 12 million.	22-06-08	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.	22-06-07	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-17	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-18	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-01	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi announces an Equity Buyback for 1,000,000 shares, for TRY 12 million.	21-09-22	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi authorizes a Buyback Plan.	21-09-21	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi(IBSE:TRILC) added to S&P Global BMI Index	21-09-20	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-06	CI
Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-30	CI

Chart Turk Ilac Ve Serum Sanayi Anonim Sirketi

Duration

Period

Chart Turk Ilac Ve Serum Sanayi Anonim Sirketi

More charts

Turk Ilac ve Serum Sanayi AS is a Turkey-based pharmaceutical company. The main activity of the Company is to manufacture and sell all kinds of tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids and other chemical substances. The company also acts as the representative or sales agency of other domestic and foreign pharmaceutical companies, as well as importing and marketing veterinary, cosmetics and pesticides. Turk Ilac manufactures in accordance with Current Good Manufacturing (GMP) and Good Laboratory Practice (GLP) principles with its approximately 300 employees in its facilities on a total area of 56.000 square meters in the Ankara - Akyurt region.

Sector

Pharmaceuticals

Calendar

2024-04-29 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TURK ILAC VE SERUM SANAYI ANONIM SIRKETI	+108.40%	116M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.16%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.92%	231B
NOVARTIS AG	+4.97%	200B
ROCHE HOLDING AG	-9.41%	195B
AMGEN INC.	-6.26%	145B